Kyeo-Jin Kim

Title: Innovator Spotlight: Kyeo-Jin Kim

Introduction

Kyeo-Jin Kim, an accomplished inventor based in Seoul, South Korea, has made significant contributions to the field of pharmaceuticals. With a focus on metabolic diseases and liver conditions, his innovations aim to enhance therapeutic methods and improve patient outcomes.

Latest Patents

Kyeo-Jin Kim holds two patents that center around isoxazole derivatives as nuclear receptor agonists. The first patent outlines methods for treating or ameliorating metabolic diseases, cholestatic liver diseases, or organ fibrosis through pharmaceutical compositions containing isoxazole derivatives. These compounds can exist in various forms, including racemates, enantiomers, diastereoisomers, or their pharmaceutically acceptable salts. The second patent details the preparation and use of isoxazole derivatives specifically for the activation of the Farnesoid X receptor (FXR, NR1H4), a critical component in managing metabolic and liver diseases.

Career Highlights

Kyeo-Jin Kim is currently contributing his expertise at Il Dong Pharmaceutical Co., Ltd., where he is at the forefront of drug development and innovation. His work focuses on creating novel therapeutic solutions that leverage advanced medicinal chemistry.

Collaborations

Throughout his career, Kim has collaborated with notable professionals, including Jae-Hoon Kang and Hong-Sub Lee. These partnerships foster a dynamic environment for research and development, further enhancing the potential impact of their innovations.

Conclusion

Kyeo-Jin Kim continues to make strides in pharmaceutical innovation, with his patents paving the way for new treatments in metabolic and liver diseases. His ongoing work at Il Dong Pharmaceutical Co., Ltd. ensures that he remains a vital player in advancing medical science and improving health outcomes for patients worldwide.